European Archives - Page 40 of 1095 - European Medical Journal

EMJ Reproductive Health 11 [Supplement 1] 2025

Expand your understanding of cardiovascular (CV) health in women experiencing menopause, and stay ahead of developments in women’s…

Cardiovascular health in menopause

A distinguished panel of experts elaborated on different aspects of cardiovascular health in women receiving menopausal hormone therapy…

Study Finds No Overall Association Between Hormone Therapy and Glioma

A new study suggests that hormone therapy (HT) does not significantly increase the risk of glioma in postmenopausal women, except for a potential elevated risk in women with higher education. Researchers call for further investigation into these subgroup differences.

Tuberculosis Vaccine Trial Shows No Protection Against Recurrence

A Phase IIb clinical trial evaluating the tuberculosis vaccine H56:IC31 has found no evidence that it reduces the risk of recurrent disease in individuals who have completed treatment for pulmonary tuberculosis.

Xavier Leleu

Hema Now: Episode 12: Breaking Boundaries in Multiple Myeloma Research

Xavier Leleu, Head of the Department of Hematology at Centre Hospitalier Universitaire (CHU), Université de Poitiers, France

UDCA May Reduce Need for Surgery in Gallstone Management After Bariatric Surgery

Ursodeoxycholic acid (UDCA) may provide a safe and effective alternative to surgery for dissolving gallstones in patients who have undergone sleeve gastrectomy, according to a new study. Gallstones dissolved in 60% of patients treated with UDCA, with fewer hospitalisations and mild side effects.

ESGO 2025 Insights: An Interview with Bradley Monk

Bradley Monk discusses ground-breaking innovations and the future of gynaecologic oncology from ESGO 2025.

Investigating Probiotics for Managing Atopic Dermatitis in Infants

Recent research highlights the role of gut microbiota in atopic dermatitis pathogenesis.

EMJ Dermatology 13 [Supplement 1] 2025

Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…

Nemolizumab in Atopic Dermatitis

Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…